Yuki Imura

1.7k total citations
44 papers, 1.3k citations indexed

About

Yuki Imura is a scholar working on Immunology, Biomedical Engineering and Hematology. According to data from OpenAlex, Yuki Imura has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 7 papers in Biomedical Engineering and 6 papers in Hematology. Recurrent topics in Yuki Imura's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), 3D Printing in Biomedical Research (4 papers) and Blood properties and coagulation (3 papers). Yuki Imura is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), 3D Printing in Biomedical Research (4 papers) and Blood properties and coagulation (3 papers). Yuki Imura collaborates with scholars based in Japan, United States and Belgium. Yuki Imura's co-authors include Etsuro Yoshimura, Kiichi Sato, Zen‐ichi Terashita, Kohei Nishikawa, John F. Federici, Luiz Henrique Catalani, George Collins, Susumu Tsushima, Masaki Kawamura and A. Shino and has published in prestigious journals such as Blood, Journal of Applied Physics and Analytical Chemistry.

In The Last Decade

Yuki Imura

42 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Imura Japan 20 449 271 199 173 151 44 1.3k
Shaoxi Cai China 23 240 0.5× 425 1.6× 96 0.5× 229 1.3× 119 0.8× 81 1.3k
Manasa K. Nayak United States 22 300 0.7× 424 1.6× 199 1.0× 57 0.3× 84 0.6× 41 1.5k
Marilena Crescente United Kingdom 19 214 0.5× 249 0.9× 343 1.7× 64 0.4× 64 0.4× 40 1.2k
Rafael Moreno‐Luna Spain 22 228 0.5× 436 1.6× 189 0.9× 67 0.4× 180 1.2× 56 1.5k
Manuela Călin Romania 22 173 0.4× 372 1.4× 94 0.5× 179 1.0× 88 0.6× 58 1.2k
Zheng Zhang China 23 329 0.7× 763 2.8× 146 0.7× 76 0.4× 81 0.5× 73 1.7k
Mitsuko Takenaga Japan 22 156 0.3× 533 2.0× 66 0.3× 119 0.7× 107 0.7× 67 1.6k
Houyuan Hu China 21 459 1.0× 578 2.1× 145 0.7× 86 0.5× 52 0.3× 44 1.8k
Stephen F. Rodrigues Brazil 20 97 0.2× 352 1.3× 190 1.0× 78 0.5× 149 1.0× 38 1.2k
Marie‐Noëlle Giraud Switzerland 27 389 0.9× 471 1.7× 295 1.5× 144 0.8× 86 0.6× 82 1.9k

Countries citing papers authored by Yuki Imura

Since Specialization
Citations

This map shows the geographic impact of Yuki Imura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Imura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Imura more than expected).

Fields of papers citing papers by Yuki Imura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Imura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Imura. The network helps show where Yuki Imura may publish in the future.

Co-authorship network of co-authors of Yuki Imura

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Imura. A scholar is included among the top collaborators of Yuki Imura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Imura. Yuki Imura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Takemoto, Kana, et al.. (2025). Human PBMC-based humanized mice exhibit myositis features and serve as a drug evaluation model. Inflammation and Regeneration. 45(1). 1–1. 2 indexed citations
3.
Miyakoshi, Kei, Noriyuki Iwama, Hiroshi Yamashita, et al.. (2024). Gestational diabetes in early pregnancy is associated with postpartum glucose intolerance: A perspective from the diabetes and pregnancy outcome for mother and baby study in Japan. Journal of Diabetes Investigation. 16(3). 535–542. 2 indexed citations
4.
Ogawa, Shinya, et al.. (2020). Post-column detection of cadmium chelators by high-performance liquid chromatography using 5,10,15,20-tetraphenyl-21H,23H-porphinetetrasulfonic acid. Journal of Chromatography B. 1141. 122025–122025. 5 indexed citations
5.
Kondo, Taisuke, Yuki Imura, Makoto Ando, Shunsuke Chikuma, & Akihiko Yoshimura. (2019). In Vitro Conversion of Activated T Cells into Stem Cell Memory-Like T Cells. Methods in molecular biology. 2048. 41–51. 5 indexed citations
6.
Atsumi, Takashi, Takeshi Takeuchi, Noriyuki Satoh, et al.. (2018). Structural and functional analyses of calcium ion response factors in the mantle of Pinctada fucata. Journal of Structural Biology. 204(2). 240–249. 6 indexed citations
7.
Yamamoto, Toshiyoshi, et al.. (2018). Decreased aluminium tolerance in the growth of Saccharomyces cerevisiae with SSO2 gene disruption. BioMetals. 31(2). 203–215. 7 indexed citations
8.
Furihata, Kazuo, et al.. (2016). Formation of gold nanoparticles by glycolipids of Lactobacillus casei. Scientific Reports. 6(1). 34626–34626. 45 indexed citations
9.
Imura, Yuki, et al.. (2016). Determination of ferric iron chelators by high-performance liquid chromatography using luminol chemiluminescence detection. Journal of Chromatography B. 1014. 75–82. 9 indexed citations
10.
Ito, Kyoko, et al.. (2015). High-performance liquid chromatography method for ferric iron chelators using a post-column reaction with Calcein Blue. Journal of Chromatography B. 985. 48–53. 3 indexed citations
11.
Yasuda, Daisuke, Yuki Imura, Satoshi Ishii, Takao Shimizu, & Motonao Nakamura. (2015). The atypical N‐glycosylation motif, Asn‐Cys‐Cys, in human GPR109A is required for normal cell surface expression and intracellular signaling. The FASEB Journal. 29(6). 2412–2422. 12 indexed citations
12.
Imura, Yuki, Etsuro Yoshimura, & Kiichi Sato. (2012). Micro Total Bioassay System for Oral Drugs: Evaluation of Gastrointestinal Degradation, Intestinal Absorption, Hepatic Metabolism, and Bioactivity. Analytical Sciences. 28(3). 197–199. 54 indexed citations
13.
Imura, Yuki, et al.. (2012). Substrate Inhibition Competes with Halide Inhibition in Polyphenol Oxidase. The Protein Journal. 31(7). 609–614. 8 indexed citations
14.
Imura, Yuki, et al.. (2009). A Microfluidic System to Evaluate Intestinal Absorption. Analytical Sciences. 25(12). 1403–1407. 130 indexed citations
15.
Kawamura, Masaki, Yuki Imura, Hideto Fukushi, et al.. (1996). Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.. Journal of Pharmacology and Experimental Therapeutics. 277(1). 502–510. 27 indexed citations
16.
Kawamura, Masaki, Zen‐ichi Terashita, Yuki Imura, A. Shino, & Kohei Nishikawa. (1993). Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: Possible role of PAF in tissue factor generation. Thrombosis Research. 70(4). 281–293. 15 indexed citations
17.
Imura, Yuki, et al.. (1991). Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.. PubMed. 21B. 943–6. 8 indexed citations
18.
Imura, Yuki, JM Stassen, S Bunting, Filip Stockmans, & Désiré Collen. (1991). ANTITHROMBOTIC PROPERTY OF G4120, A CYCLIC ARG-GLY-ASP CONTAINING PEPTIDE, IN A HAMSTER PLATELET-RICH FEMORAL VEIN-THROMBOSIS MODEL. Thrombosis and Haemostasis. 65(6). 812–812. 3 indexed citations
19.
Imura, Yuki, Zen‐ichi Terashita, & Kohei Nishikawa. (1990). The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage. Thrombosis Research. 59(1). 195–205. 15 indexed citations
20.
Terashita, Zen‐ichi, et al.. (1987). CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.. Journal of Pharmacology and Experimental Therapeutics. 242(1). 263–268. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shaoxi Cai Breakdown of academic impact, for papers by Manasa K. Nayak Breakdown of academic impact, for papers by Marilena Crescente Breakdown of academic impact, for papers by Rafael Moreno‐Luna Breakdown of academic impact, for papers by Manuela Călin Breakdown of academic impact, for papers by Zheng Zhang Breakdown of academic impact, for papers by Mitsuko Takenaga Breakdown of academic impact, for papers by Houyuan Hu Breakdown of academic impact, for papers by Stephen F. Rodrigues Breakdown of academic impact, for papers by Marie‐Noëlle Giraud
Rankless by CCL
2026